FDA Prompts Removal of Unapproved Drugs from Market
Wednesday, 02 March 2011 23:19
Class action is part of FDA’s Unapproved Drugs Initiative
(FDA.gov) - The U.S. Food and Drug Administration today took action against companies that manufacture, distribute, or market certain unapproved prescription oral cough, cold, and allergy products. The affected products cannot be legally marketed in the United States.
Unapproved prescription cough, cold, and allergy drug products have not been evaluated by the FDA for safety, effectiveness, and quality. People may be at greater risk when using these products than when using FDA-approved prescription drugs or drugs that are appropriately marketed over-the-counter (OTC).
Pension Funds to File Complaint Against BP in Securities Class-Action
Monday, 14 February 2011 23:24
The Complaint alleges that BP was wholly unprepared to prevent and deal with the BP Deepwater Horizon disaster.
(COLUMBUS, Ohio) – Ohio Attorney General Mike DeWine, acting in his capacity as counsel for lead plaintiffs for a class of pension plans and investors around the country, authorized the filing today in U.S. District Court in Houston of a consolidated class-action against British Petroleum (BP) and other defendants.
"In the wake of the BP Deepwater Horizon spill, in addition to the tragic loss of life and environmental damage, pension systems providing retirement benefits for current and future retirees who invested in BP in good faith were adversely affected when stock prices plummeted."
